
Pharmexcil seeks explanation from eye drops maker flagged by Sri Lanka
The Hindu
Pharmaceutical exporters body Pharmexcil has sought an explanation from Indiana Ophthalmics LLP in the wake of the Sri Lankan Ministry of Health directing the company to recall eye drops as its usage was recently linked to eye infections in some people.
Pharmaceutical exporters body Pharmexcil has sought an explanation from Indiana Ophthalmics LLP in the wake of the Sri Lankan Ministry of Health directing the company to recall eye drops as its usage was recently linked to eye infections in some people.
Pharmexcil has set June 3 as deadline for the Gujarat firm to furnish details of the licensees and importers to whom the drug was supplied as well as the manufacturing licence copies. The company, which is registered as a small-scale manufacturer, was also directed to investigate reasons for the contamination of the alleged product.
Failure to provide the information will result in suspension of the company’s registration cum membership certificate, Pharmexcil Director General Ravi Udaya Bhaskar said. The Central Drugs Standard Control Organisation (CDSCO) has already launched an investigation following the complaint by the Sri Lankan Ministry.

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












